Aloprim — Class II drug recall D-1271-2020
Terminated recall by Mylan Institutional LLC, reported 2020-05-27, distributed nationwide. Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the en
| Recall number | D-1271-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mylan Institutional LLC, Rockford, IL, United States |
| Recall initiated | 2020-05-05 |
| Classified | 2020-05-20 |
| Reported by FDA | 2020-05-27 |
| Terminated | 2022-01-26 |
| Distributed | Nationwide (US) |
| Quantity | 3,010 vials |
| Reason classes | specification failure |
| NDC | 67457-0187, 67457-0187-50 |
| Lot numbers | N1700771, N1800127 |
| Expiration dates | 2020-10-20, 2021-02-20 |
Product
Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50
Reason for recall
Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1271-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.